Connect your AI

GeneDx Holdings WGS Gross Profit

Gross Profit at other companies

Bio-Rad LaboratoriesBIO

$309.4M+1.1%

Labcorp HoldingsLH

$1.01B+6.9%

IlluminaILMN

$721M+5.6%

Agilent TechnologiesA

$990M+14.3%

Quest DiagnosticsDGX

——

RevvityRVTY

——

Other financials

Income statement

Revenue$102.3M+17.4%

Operating income-$57.5M-1,163%

Net income-$63.3M-870%

EPS (diluted)-$2.16-839%

Balance sheet

Cash & equivalents$94.9M-5.7%

Total debt$96.7M+82.5%

Total equity$254.1M-1.3%

Total assets$506.3M+13.4%

Cash flow

Operating cash flow-$32.4M-418%

CapEx$6.5M+5.3%

Free cash flow-$38.9M-1,059%

Valuation

Market cap$1.72B-24.3%

Enterprise value$1.73B-22.8%

P/S3.9×-3.0×

Profitability

Gross margin69.6%+4.3pp

Operating margin-14.9%—

Net margin-17.6%—

FCF margin3.8%+2.1pp

Returns & leverage

Return on equity-30.4%—

Debt / equity0.4×+0.2×

Current ratio3.1×-0.2×

Where this comes from

Calculated from GeneDx Holdings’s reported figures.

$102.3Mtotal revenue−$34.0Mtotal cost of revenue=$68.21M

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is GeneDx Holdings's gross profit?: GeneDx Holdings (WGS) reported gross profit of $68.21M in Q1 2026.
How has GeneDx Holdings's gross profit changed year-over-year?: GeneDx Holdings's gross profit increased by 16.6% year-over-year, from $58.48M to $68.21M.
What is the long-term trend for GeneDx Holdings's gross profit?: Over 4 years (2021 to 2025), GeneDx Holdings's gross profit has grown at a 105.9% compound annual growth rate (CAGR), from -$16.6M to $298.17M.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.